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Abstract
Background: Clearance of inhaled technetium-labeled diethylenetriamine pentaacetate (99mTc-
DTPA) is a marker of epithelial damage and an index of lung epithelial permeability. The aim of this
study was to investigate the role of 99mTc-DTPA scan in patients with Idiopathic Pulmonary Fibrosis
(IPF). Our hypothesis is that the rate of pulmonary 99mTc-DTPA clearance could be associated with
extent of High Resolution Computed Tomography (HRCT) abnormalities, cell differential of
bronchoalveolar lavage fluid (BALF) and pulmonary function tests (PFTs) in patients with IPF.
Methods: We studied prospectively 18 patients (14 male, 4 female) of median age 67yr (range 55–
81) with histologically proven IPF. HRCT scoring included the mean values of extent of disease.
Mean values of these percentages represented the Total Interstitial Disease Score (TID). DTPA
clearance was analyzed according to a dynamic study using a Venticis II radioaerosol delivery
system.
Results: The mean (SD) TID score was 36 ± 12%, 3 patients had mild, 11 moderate and 4 severe
TID. Abnormal DTPA clearance half-time (t1/2<40 min) was found in 17/18 (94.5%) [mean (SD) 29.1
± 8.6 min]. TID was weakly correlated with the DTPA clearance (r = -0.47, p = 0.048) and with %
eosinophils (r = 0.475, p = 0.05). No correlation was found between TID score or DTPA and PFTs
in IPF patients.
Conclusion: Our data suggest that 99mTc-DTPA lung scan is not well associated with HRCT
abnormalities, PFTs, and BALF cellularity in patients with IPF. Further studies in large scale of
patients are needed to define the role of this technique in pulmonary fibrosis.
Background
Clearance of inhaled technetium-labeled diethylenetri-
amine pentaacetate (99mTc-DTPA) is an index of lung epi-
thelial permeability [1,2]. The technique is non invasive,
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relatively inexpensive with a low radiation, and easy to
perform using standard equipment in clinical nuclear
medicine department [3].
Abnormal 99mTc-DTPA has been found in several intersti-
tial lung diseases [4,5]. It has been used as a marker of
alveolar inflammation in sarcoidosis [4] and could poten-
tially be used as a predictor of disease progression in idio-
pathic pulmonary fibrosis (IPF) [5]. In interstitial lung
disease (ILD), active inflammation in the lower respira-
tory tract results in lung injury and fibrosis. On the con-
trary, recent data suggests that inflammation does not
play a pivotal role in IPF [6]. Evidence suggests that epi-
thelial injury, even in the absence of inflammation is suf-
ficient to stimulate the development of fibrosis [6].
High-resolution computed tomography (HRCT) has diag-
nostic and prognostic value, and should be a part of the
initial evaluation of ILD [7]. The extent of IPF on HRCT
correlates roughly with severity of functional impairment
(i.e, FVC and DLCO [8].
The objective of this study was to explore the role of 99mTc-
DTPA scanning in a well-defined population of IPF
patients. In addition, our aim was to determine whether
DTPA clearance is correlated with HRCT score, BALF dif-
ferential cell counts and pulmonary function tests (PFTs).
Methods
Patients
Eighteen consecutive IPF patients who were investigated
at our departments were enrolled in the study. The diag-
nosis of IPF was based on recently established criteria [9]
and confirmed by lung biopsy with video-assisted thora-
coscopic surgery (VATS). The histologic appearance was
that of usual interstitial pneumonia (UIP) and all patients
were newly diagnosed.
All patients (14 male, 4 female) of median age 67 yr
(range, 55–81), were studied prospectively. Patients were
excluded from the study if they were current smokers (ces-
sation of smoking at least 6 months prior to the measure-
ment of DTPA clearance was a prerequisite for the
enrollment).
Spirometry
Spirometry was performed with a computerized system
(MasterLab, Jaeger 2.12, Germany). The measurement
was performed using standard protocols according to
American Thoracic Society (ATS) guidelines [10]. Subjects
did not use short acting bronchodilators within 12 hours
prior to the measurements. The best of three consecutive
measurements was chosen.
HRCT in IPF patients
The HRCT slices were evaluated at five predetermined lev-
els: the aortic arch, the tracheal carina, the pulmonary
hilar, the pulmonary venous confluence, and 1–2 cm
above the right hemidiaphragm. The scans were per-
formed with 1 mm thickness and 1 to 2 sec scanning time
during breath holding at end inspiration. High spatial fre-
quency algorithm was used and images were read at win-
dow levels appropriate for pulmonary parenchyma (level-
600 to-700 Hounsfield units; window 1500–1600).
HRCT scoring in IPF patients included extent of disease at
each of the above mentioned levels at the level of 5%
using a visual method of assessment similar to that used
previously by the same [11] and other investigators [8,12-
15]. Two experienced readers, first independently without
any knowledge of the clinical and functional findings and
subsequently- in cases in which there were discrepancies-
with consensus, examined the HRCT scans.
HRCT scoring included extent of overall involvement of
lung parenchyma at each HRCT slice at the nearest 5%
(range 0–100) using a visual method of assessment simi-
lar to that used previously by other investigators [8,11-
15]. The total interstitial disease score (TIDs) was calcu-
lated by the sum of all the above mentioned percentages
divided by five-the number that represented the number
of the slices evaluated. Interestingly, scores from the five
HRCT slices were summed and divided by the total
number of slices to calculate the average extent score for
each of the variables. Similar methods of scoring have
been used by Staples and coworkers [12], Lee and cowork-
ers [13] and Wells and co-workers [8,15]. Lung paren-
chyma involvement was classified as 0–20%: mild (grade
1), 21–40%: moderate (grade 2), >40%: severe (grade 3).
The classification of severity of disease in mild, moderate
and severe is somehow arbitrarily made based on the TID
obtained from the above calculations.
99mTc-DTPA scan
An aerosol of Tc-99m diethylenetriamine pentaacetate
(DTPA) was produced using a Venticis II radioaerosol
delivery system (CIS bio international, Cedex, France).
The radioaerosol was administered to patients for 4 min-
utes. A dynamic study consisting of 30 one-minute frames
were then acquired by a GE Millennium MPS γ-camera
(GE, Milwuakee, Wisconsin, USA).
Regions of interest (ROI) were identified on either lung
and a background ROI was set. Background subtraction
was employed and an exponential fit of the clearance of
each lung was derived starting from the frame with peak
activity. The half-time of clearance was estimated in min-
utes for each lung and the average value was obtained. A
clearance half-time of <40 min was regarded as abnormal.BMC Pulmonary Medicine 2006, 6:4 http://www.biomedcentral.com/1471-2466/6/4
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A clearance half-time of less than 20 min (50% of normal)
was categorized as very rapid [4,5,16].
Bronchoalveolar lavage
Fiberoptic bronchoscopy with BAL was performed as part
of routine clinical management, according to recom-
mended guidelines and previous reports [17].
Subjects were premedicated with atropine 0.5 mg IM, and
the airways were anesthetized by inhalation of 4% xylo-
caine. Supplemental oxygen was administered during and
immediately after the procedure. Oxygen saturation and
ECG tracings were monitored during the procedure. After
the administration of 2% topical xylocaine, the broncho-
scope was inserted transnasally and, after inspection of
segmental orifices, it was wedged according to a standard
protocol in the middle lobe or the lingula. Aliquots of 60
ml of sterile normal saline previously warmed to 37°C
instilled through the bronchoscope, and the fluid was
retrieved by mechanical suction. The standard introduc-
tion volume was 180 ml and the recovery volume >60%
in all cases. The cells were recovered by gentle aspiration.
Slide preparations for differential percentage counting of
cells were made in a cytocentrifuge (Aero spray, Wescor,
USA) using 50-µL aliquots of the lavage cell suspensions.
Two slides were stained with May-Grunewald-Giemsa
stain. Differential counts were made by two independed
observers for a minimum count of 500 nucleated non
squamous cells. Visually identified squamous epithelial
cells were not included in the total cell count. Addition-
ally, 300 µL of BALF were processed for flow cytometric
analysis.
All the above investigations (spirometry, bronchoalveolar
lavage fluid, HRCT and DTPA scan) are incorporated in
the routine follow-up of our hospital. An ethical approval
was not necessary to be asked.
Statistical analysis
All analyses were performed using the statistical software
Stats-Disect for Windows version 1.8.9 (Camcode, Cam-
bridge, UK). Results are expressed as mean + 1SD, or
median (range), unless other indicated. The Kolmogorov-
Smirnof test for normality was applied to examine data
distribution. Differences between the two groups of sub-
jects were tested using the Mann-Whitney U test. Correla-
tion between cell and physiological variables were
analyzed using Spearman's rank correlation coefficient. A
p value of < 0.05 was considered as statistically significant.
Results
The demographic and clinical characteristics of the IPF
patients are shown in table 1.
The mean (SD) TID score was 36 ± 12%, 3 patients had
mild, 11 moderate and 4 severe TID. Abnormal DTPA
clearance half-time (t1/2<40 min) was found in 17 of
the18 (94.5%) IPF patients [mean (SD) 29.1 ± 8.6 min].
A weak association was found between TID score and
DTPA clearance (r = -0.47, p = 0.048) (Figure 1). No cor-
relation was found between TID score or DTPA and PFTs
in IPF patients.
The total and the differential cell counts of BALF are
shown in Table 2. TID score was weakly correlated with
eosinophils (r = 0.475, p = 0.05) (Figure 2) and negatively
with macrophages (r = -0.507, p = 0.03).
Discussion
This is the first study to systematically evaluate newly
diagnosed IPF patients with biopsy proven histology of
usual interstitial pneumonia (UIP), excluding the other
clinical-pathologic entities of idiopathic interstitial pneu-
monias, comparing quantitatively the extent of abnormal-
ities in the HRCT and 99mTc-DTPA clearance
prospectively. We found that the 99mTc-DTPA clearance
time is abnormal in almost all (94.5%) of IPF patients.
On the contrary, we failed to detect a strong correlation
between HRCT TID score and 99mTc-DTPA clearance. An
additional finding of this study is a weak linkage between
TID score and eosinophils in BALF.
In a recent prospective study Mogulkoc et al. [16] evalu-
ated the potential ability of 99mTc-DTPA scanning in pre-
dicting survival in a large scale population of 106 IPF
patients. On the other hand, only 30% of them had histo-
logically proven disease. The authors showed that the pre-
dictive value of this technique (in terms of survival) was
lower than that of total lung capacity and DLCO. They
Table 2: Mean ± SD of total and percentage (± SD) of differential 
cell counts in BALF in 18 IPF patients.
Cell Type
Total cell count, ×105/mL 28.6 ± 3.2
Macrophages,% 82.2 ± 4.3
Lymphocytes,% 7.7 ± 3.0
Neutrophils,% 6.23 ± 2.2
Eosinophils, % 3.7 ± 2.4
Table 1: IPF patients characteristics
Sex (Male/Female) 14/4
Age, range, yr (mean ± SD) 55–81 (67 ± 7.3)
FVC% pred, x ± SD 76.1 ± 11.5
FEV1%pred, x ± SD 81.9 ± 14.5
TLC% pred, x ± SD 62.7 ± 9.4
TLCO% pred, x+SD 68.0 ± 12.2BMC Pulmonary Medicine 2006, 6:4 http://www.biomedcentral.com/1471-2466/6/4
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Correlation of DTPA clearance and HRCT TID score in IPF  patients Figure 1
Correlation of DTPA clearance and HRCT TID score in IPF 
patients.
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also detected that the clearance values did not correlate
with the HRCT scoreby using a both mono-exponential
and bi-exponential analysis [16], in accordance with our
data. In line with these findings, a recent published study
has shown that clearance of inhaled 99mTc-DTPA is not of
value in following the progress of IPF [17]. Mura and cow-
orkers did not detect any significant correlation between
99mTc-DTPA and functional tests or HRCT score [18].
DTPA scan has been used in the repertoire of investiga-
tions in a number of diffuse parenchymal diseases [19-25]
but all of them were before the recent revision of the his-
tological classification of IPF [26].
The specific mechanism of increased clearance time in IPF
is still unclear but has been thought to be secondary to the
stretching of epithelial junctions in the alveolar wall as a
result of fibrotic traction or lymphocytic infiltration
[27,28]. We speculate that the rapid clearance may occur
across the bare basement membrane, denuded of epithe-
lium, which has been demonstrated in ultrastructural
studies of IPF [29].
We found no correlation between aerosol clearance and
pulmonary function parameters, in agreement with the
findings of previous studies [16,18-20]. Similarly, only a
weak correlation between DTPA clearance and % pre-
dicted TLCO was found in patients with sarcoidosis and
scleroderma [21-23]. The consistent absence of a correla-
tion may be because the impairment of pulmonary func-
tion parameters is a result of the maldistribution of
ventilation and perfusion or loss of surface area, while the
increased rate of DTPA clearance is caused by increased
junctional permeability in the alveolar capillary mem-
branes [16].
Wells et al. reported that depression of TLCO and FVC
were positively related to the extent of disease on the CT
scan and that there were no independent relationships
between functional indices and the pattern or distribution
of disease on the CT scan [8,15,30]. We did not find sim-
ilar correlation between TID score or DTPA and PFTs in
our IPF population. We have used TID score in the evalu-
ation of HRCT scans, which is a similar technique of esti-
mating disease extent applied in previous studies
[8,11,16,30]. In detail, this method of scoring is similar to
that used by Staples and coworkers [12] and Lee and cow-
orkers [13] represents a slight modification of the scoring
system used by Wells and coworkers [8,15,30]. It was
recently used by our radiologist in the evaluation of dysp-
nea in IPF [11]. One of the findings of the aforementioned
study was that TIDs was significantly associated with FVC,
FEV1, TLC and PaO2 [11]. On the other hand, in the stud-
ies of Staples [12] and Terriff [31], FVC was not correlated
with the HRCT scores. Wells et al. found that the extent of
fibrosing alveolitis and the presence of emphysema are
independent determinants of functional impairment by
using a multivariate analysis model [32]. This observation
Correlation of HRCT TID score and % of eosinophils in  BALF Figure 2
Correlation of HRCT TID score and % of eosinophils in 
BALF.
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leads to the premese that quantification of disease severity
using pulmonary function tests is often confounded by
emphysema [32]. The above discrepancies among previ-
ous studies and the present results are difficult to explain
but may be related to the variable course of the disease, to
the fact that somewhat different methodologies have been
used [11,12,15,31,33] and also to the fact that some pre-
vious works included patients with interstitial lung dis-
ease associated with conditions such as connective tissue
disorders [12,15,34]. In addition, we speculate that differ-
ences could be derived from the fact that we have not esti-
mated the percentage of emphysema. Furthermore,
Kazerooni and coworkers have used a different, in our
opinion more complicated, HRCT scoring system [33],
and demonstrated an excellent correlation between HRCT
and pathology fibrosis score.
We found a moderately significant correlation of DTPA
clearance with the visual score in HRCT in 18 patients
with IPF. We could not overestimated these results
because are based only on a limited number of subjects
and on a correlation factor of -0.47; it should be sup-
ported by a follow-up study in order to investigate if the
clearance of 99m-DTPA can actually predict the clinical
course of IPF. Furthermore, a recent study demonstrated
that clearance of 99m-DTPA, although abnormal in all
subjects in presentation, was not a predictor of disease
progression in IPF patients [17]. Additionally, Mogulkoc
et coworkers showed that the predictive value of the afore-
mentioned technique (in terms of survival) was lower
than that of total lung capacity and DLCO, and the clear-
ance values did not correlate with the HRCT score [17].
However, this study differs from ours in that it focuses on
the resolution of the DTPA clearance into fast and slow
components. Harrison et al. reported that when the CT
scan is normal, abnormalities of BAL and/or DTPA clear-
ance may indicate lung disease at a still earlier stage in
patients with systemic sclerosis [24].
We also found a moderate correlation between BAL eosi-
nophilia and HRCT TID score. It has been shown that
excess neutrophils and/or eosinophils (>5%) in the BALF
have been associated with a higher likelihood of disease
progression and a failure to respond to immunosuppres-
sion [9].
Conclusion
Our data suggest that at the moment there are not suffi-
cient evidences to recommend the implementation of
99mTc-DTPA lung scan in the follow-up of IPF patients.
Further prospective studies in a large scale and well-
defined IPF population are necessary to define the role of
this modern technique in the evaluation of pulmonary
fibrosis.
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